https://bukopharma.de/pharmabrief/pharma-brief-1-2026-ataluren-jahresrueckblick-und-malariabekaempfung/usa-medizinische-informationssysteme-bedroht/
#Forschung #Transparenz #PubMed #USA
@longcovid, others...
Based on one of your replies I was interested to see how #LongCOVID shows up in the NIH #PubMed database. It appears that LongCOVID has not been fully recognized (by MeSH index terms) at this time. There is a new term "Post-Acute COVID-19 Syndrome" for some/all of the brain related conditions (first screen shot). For perspective... the new term yields 4K+ articles while the bare word "long covid" search yields approx 10x that.
Both searches show significant declines since 2022/23. 🙁
Don't know if these will come thru but here are the search links for anyone interested...
https://pubmed.ncbi.nlm.nih.gov/?sort=date&term=%22Post-Acute+COVID-19+Syndrome%22%5BMesh%5D
Omega-3 is inversely related to risk of early-onset dementia

This study expands the evidence of a beneficial association of omega-3 and LOD to EOD as well. These findings suggest that an increased intake of omega-3 fatty acids earlier in life may slow the development of EOD. Additional research is needed to confirm our findings, particularly in more diverse p …
The PubMed trap: Germany’s dangerous data poker in medicine.
When PubMed, the world’s largest medical literature database, went offline for a day, German science was suddenly made aware of how precariously it stands.
The German government promised digital sovereignty and provides millions, but behind the scenes, a dispute rages over securing important research data.
#Healthcare #PubMed #Medicine #Germany #DataSovereignty #OLSPub #ZBMED #Tech #Research #Science #Europe